Conducting clinial study to compare effect of Haridrakhand vati after virechan karma in fisrt group and only Haridrakhand vati in second group in the management of Urticaria.

Randomised controlled clinical study to evaluate the efficacy of virechanottar Haridrakhand vati and Haridrakhand vati in the management of sheetpitta w.r.t. Urticaria. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072881

Enrollment

100

Registered

2024-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 20-60yrs of age. 2. Must have chronicity more than 6 weeks. 3. patients with classic symptoms of urticaria like Varati damshavat shoth,Kandu,Toda,Vidaha,frequent attacks. 4. Patients of either sex.

Exclusion criteria

Exclusion criteria: 1. Patients less than 20 yrs and more than 60 yrs of age. 2. Patients with other major pathologies like DM,TB,Urticaria with any other skin disease,SLE,angioedema. 3. Acute urticaria will be excluded. 4. History of allergy to any medicine.

Design outcomes

Primary

Measure	Time frame
Improvement in clinical symptoms-Parameters such as itching,wheals,burning sensation,pricking pain after purgation therapy along with 30 days of internal medicine.Timepoint: 45 DAYS	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDrAshish Mhatre

D.Y.Patil deemed to be university

ashishmhatre2010@gmail.com9819639895

Outcome results